54 related articles for article (PubMed ID: 14565653)
1. Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Kim TK; Xu ML; Podoltsev NA; Prebet T; Barbarotta L; Amin K; Kasberg S; Roche K; Stahl M; Gore SD; Zeidan AM
Ann Hematol; 2016 Oct; 95(11):1895-8. PubMed ID: 27468851
[No Abstract] [Full Text] [Related]
2. Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses.
Ness KK; Hudson MM; Pui CH; Green DM; Krull KR; Huang TT; Robison LL; Morris EB
Cancer; 2012 Feb; 118(3):828-38. PubMed ID: 21766297
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
Cassaday RD; Zarling LC; Garcia KA; Sala-Torra O; Stevenson PA; Martino CH; Liu YJ; Fang M; Percival MM; Halpern AB; Becker PS; Oehler VG; Shustov AR; Cooper JP; Orozco JJ; Hendrie PC; Walter RB; Radich JP; Soma LA; Estey EH
Leuk Lymphoma; 2023 May; 64(5):927-937. PubMed ID: 36938892
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.
Domenech C; Suciu S; De Moerloose B; Mazingue F; Plat G; Ferster A; Uyttebroeck A; Sirvent N; Lutz P; Yakouben K; Munzer M; Röhrlich P; Plantaz D; Millot F; Philippet P; Dastugue N; Girard S; Cavé H; Benoit Y; Bertrandfor Y;
Haematologica; 2014 Jul; 99(7):1220-7. PubMed ID: 24727815
[TBL] [Abstract][Full Text] [Related]
5. Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia.
Hijiya N; Panetta JC; Zhou Y; Kyzer EP; Howard SC; Jeha S; Razzouk BI; Ribeiro RC; Rubnitz JE; Hudson MM; Sandlund JT; Pui CH; Relling MV
Blood; 2006 Dec; 108(13):3997-4002. PubMed ID: 16917005
[TBL] [Abstract][Full Text] [Related]
6. Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.
De Moerloose B; Suciu S; Bertrand Y; Mazingue F; Robert A; Uyttebroeck A; Yakouben K; Ferster A; Margueritte G; Lutz P; Munzer M; Sirvent N; Norton L; Boutard P; Plantaz D; Millot F; Philippet P; Baila L; Benoit Y; Otten J;
Blood; 2010 Jul; 116(1):36-44. PubMed ID: 20407035
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B.
Gottlieb AJ; Weinberg V; Ellison RR; Henderson ES; Terebelo H; Rafla S; Cuttner J; Silver RT; Carey RW; Levy RN
Blood; 1984 Jul; 64(1):267-74. PubMed ID: 6375760
[TBL] [Abstract][Full Text] [Related]
8. Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapse.
Pavlovsky S; Muriel FS; Eppinger-Helft M; Bustelo P; Garay G; Giuntoli JM; Kvicala R; Divito J; Picón A
Cancer Treat Rep; 1983 May; 67(5):425-7. PubMed ID: 6573958
[TBL] [Abstract][Full Text] [Related]
9. Acute lymphoblastic leukemia of adulthood: progress or not?
Wiernik PH
Curr Treat Options Oncol; 2011 Dec; 12(4):303-11. PubMed ID: 21956641
[TBL] [Abstract][Full Text] [Related]
10. Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
Hunault-Berger M; Milpied N; Bernard M; Jouet JP; Delain M; Desablens B; Sadoun A; Guilhot F; Casassus P; Ifrah N
Leukemia; 2001 Jun; 15(6):898-902. PubMed ID: 11417474
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Ishii E; Nagatoshi Y; Eguchi H; Koga H; Yanai F; Inada H; Nibu K; Tamai Y; Akiyoshi K; Nakayama H; Hara T; Take H; Miyazaki S; Okamura J
Int J Hematol; 2001 Apr; 73(3):369-77. PubMed ID: 11345205
[TBL] [Abstract][Full Text] [Related]
12. Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
Weiss M
Hematol Oncol Clin North Am; 2001 Feb; 15(1):1-7, v. PubMed ID: 11253603
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
[TBL] [Abstract][Full Text] [Related]
14. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
Cassileth PA; Andersen JW; Bennett JM; Hoagland HC; Mazza JJ; O'Connell MC; Paietta E; Wiernik P
Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927
[No Abstract] [Full Text] [Related]
15. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
Larson RA; Dodge RK; Burns CP; Lee EJ; Stone RM; Schulman P; Duggan D; Davey FR; Sobol RE; Frankel SR
Blood; 1995 Apr; 85(8):2025-37. PubMed ID: 7718875
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
